Experts say the sectors are cash-rich and have loads of sensitive data to lose, making them the target of frequent cyber attacks
Just three months after a ransomware attack pulled down India’s largest drugmaker, Sun Pharmaceuticals, the threat actors went after another pharma company. Hyderabad-based Granules India was notified of a significant loss of revenue and profitability due to a cybersecurity attack in the last week of May.
This had a major effect on the operations of the business due to significant changes in IT systems and the time needed for meeting the regulatory expectations, qualifications, recertifications, and finetuning of quality and production systems, the paracetamol maker said in an exchange filing.
While the company has managed to restore production to near normalcy at present, there are backlogs and delays in the clearance of material for quality system approvals to dispatch the products for sale, it added.
The Russia-linked ransomware group LockBit has claimed accountability for the cyberattack and published portions of the data it allegedly stole. LockBit’s dark web leak site has leaked 50 percent of the data, and the rest is up for sale.
"Granules India is a company that does not know what cybersecurity and data protection are. During the pen test [penetration test] of its corporate network, we found more than 10 critical vulnerabilities that allowed access to its private data. Moreover, this company refused to protect the data of its employees, customers, partners, and investors in a case where it could and should have done so," said a note put out by the ransomware group on the dark web.